In vivo synergy of radiation and hu14.18-IL2 immunocytokine results in a memory T cell response in a syngeneic murine melanoma model

Lignende værker

• Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults with Melanoma and Children with Neuroblastoma
  af: Hank, Jacquelyn A., et al.
  Udgivet: (2009)
• Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting
  af: Buhtoiarov, Ilia N., et al.
  Udgivet: (2011)
• Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma
  af: Albertini, Mark R., et al.
  Udgivet: (2018)
• Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
  af: Albertini, Mark R., et al.
  Udgivet: (2012)
• Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG
  af: Alderson, Kory L., et al.
  Udgivet: (2012)